Gallacher Capital Management LLC Halozyme Therapeutics, Inc. Transaction History
Gallacher Capital Management LLC
- $197 Billion
- Q1 2024
A detailed history of Gallacher Capital Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Gallacher Capital Management LLC holds 9,244 shares of HALO stock, worth $476,620. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,244
Previous 11,403
18.93%
Holding current value
$476,620
Previous $421 Million
10.77%
% of portfolio
0.19%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$941 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$673 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$334 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$212 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$195 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.18B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...